US › Healthcare

bioAffinity Technologies, Inc. (BIAF)

US · Healthcare · Diagnostics & Research

$3.73-5.81%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$1.5M

Revenue YoY

+19.0%

Net profit

$-3.4M

EPS

$-0.64

Net margin

-222.8%

Key statistics

Market cap

$4.6M

Forward P/E

0.0

P/B

1.25

Book value

$8.34

EPS (TTM)

$-109.35

52-week high

$80.70

52-week low

$3.23

50-day MA

$7.11

200-day MA

$20.25

Beta

-1.25

Analyst view

with an average price target of $6.00.

Shareholding

Insiders

0.75%

Institutions

5.05%

Largest institutional holders

Fund	Stake
Sabby Management LLC	2.09%
BlackRock Inc	0.56%
Vanguard Capital Management, LLC	0.32%
Geode Capital Management, LLC	0.29%
J. Safra Sarasin Holding AG	0.24%
Vanguard Fiduciary Trust Co	0.18%
Susquehanna International Group, LLP	0.15%
Jane Street Group LLC	0.15%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for bioAffinity Technologies, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.